Denise Carter 13D and 13G filings for Quoin Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-28 4:43 pm Purchase |
2025-01-27 | 13D | Quoin Pharmaceuticals, Ltd. QNRX |
Denise Carter | 46,962 4.900% |
15,841 (+50.90%) |
Filing |
| 2025-01-02 5:20 pm Purchase |
2024-12-23 | 13D | Quoin Pharmaceuticals, Ltd. QNRX |
Denise Carter | 31,121 6.900% |
31,121 (New Position) |
Filing |